After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. The stock was recently discussed on Yahoo Finance as it revealed that 10x Genomics Expands Xenium Menu with Multi-Modal Cell Segmentation Kit and Immuno-Oncology Gene Panel.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
This NASDAQ-listed company operates within the Health Information Services industry segment, falling under the Healthcare sector. At the end of the last regular session, the stock closed at $38.00 and fluctuated between $39.30 as its day high and $37.99 as its day low. The current market capitalization of 10x Genomics Inc is $4.53B. A total of 1.62 million shares were traded on the day, compared to an average of 1.36M shares.
In the most recent transaction, Saxonov Serge sold 4,660 shares of TXG for 44.00 per share on Mar 04 ’24. After the transaction, the Chief Executive Officer now owns 842,900 company shares. In a previous transaction on Feb 22 ’24, Saxonov Serge sold 2,821 shares at 46.34 per share. TXG shares that Chief Executive Officer owns now total 847,560.
Among the insiders who sold shares, Hindson Benjamin J. disposed of 2,613 shares on Feb 22 ’24 at a per-share price of $46.34. This resulted in the insider holding 283,059 shares of TXG after the transaction. In another insider transaction, McAnear Justin J. sold 1,865 shares at $46.34 per share on Feb 22 ’24. Company shares held by the Chief Financial Officer now total 95,240.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, TXG has a high of $63.57 and a low of $33.79.
As of this writing, TXG has an earnings estimate of -$0.5 per share for the current quarter. EPS was calculated based on a consensus of 15 estimates, with a high estimate of -$0.31 per share and a lower estimate of -$0.65. The company reported an EPS of -$0.79 in the last quarter, which was -71.70% lower than expectations of -$0.46.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. TXG’s latest balance sheet shows that the firm has $587.45M in Cash & Short Term Investments as of fiscal 2021. There were $81.98M in debt and $110.36M in liabilities at the time. Its Book Value Per Share was $6.22, while its Total Shareholder’s Equity was $817.57M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TXG is Buy with a score of 4.31.
